Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
Journal of Interventional Medicine · 2019
DOI: 10.1016/j.jimed.2019.07.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Interventional Medicine, 2019. Verfasst von Yang Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Science and Technology Major Project of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
- HuiDong Senior Middle School, Huidong, Huizhou, China.
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Science and Technology Major Project of China
Zitieren
APA
Zhao, Y., Lai, J., Liang, R., He, M., & Shi, M. (2019). Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma. Journal of Interventional Medicine. https://doi.org/10.1016/j.jimed.2019.07.005
Vancouver
Zhao Y, Lai J, Liang R, He M, Shi M. Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma. Journal of Interventional Medicine. 2019. doi:10.1016/j.jimed.2019.07.005
BibTeX
@article{Zhao2019,
author = {Zhao, Yang and Lai, JiaYing and Liang, RunBin and He, MinKe and Shi, Ming},
title = {Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma},
journal = {Journal of Interventional Medicine},
year = {2019},
doi = {10.1016/j.jimed.2019.07.005}
}
EUVIMED